<DOC>
	<DOCNO>NCT02139150</DOCNO>
	<brief_summary>The purpose study see PET/CT scan use radioactive substance call [ 18F ] fluorothymidine ( FLT ) , detect monitor change tumor . Radioactive substance use PET/CT scan `` see '' cancer cell , also call radiotracers . FLT new radiotracer give people prior study . FLT PET/CT experimental scan unlike FDG ( fluorodeoxyglucose ) PET scan standard clinical scan commonly use . The investigator would like know evidence early treatment response obtain FLTPET/ CT scan treatment .</brief_summary>
	<brief_title>Serial FLT PET Imaging Cancer Patients Monitoring Response Therapy</brief_title>
	<detailed_description>This protocol `` umbrella '' `` companion '' protocol use conjunction protocol evaluate treatment response solid hematologic malignancy . The aim protocol determine PET image proliferation marker 18FFLT monitor change FLT uptake parameter , particular change standardize uptake value ( SUV ) , within tumor target lesion .</detailed_description>
	<criteria>Patients histologicallyconfirmed ( confirmation do MSKCC ) malignancy . Patients consent therapeutic protocol treatment cancer . Patients must â‰¥ 18 year old . Patients undergo PET/CT scanning ( i.e . weight limit , claustrophobia ) . Women pregnant breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>FLT PET Imaging</keyword>
	<keyword>3'deoxy-3 ' [ 18F ] fluorothymidine ( [ 18F ] FLT )</keyword>
	<keyword>CT</keyword>
	<keyword>scan</keyword>
	<keyword>14-050</keyword>
</DOC>